Well Referenced

Tag: integrative oncology

Oxygen-ozone therapy as support and palliative therapy in 50 cancer patients with fatigue – A short report

This 2018 short report by Tirelli et al. evaluated the use of oxygen-ozone autohemotherapy (O2-O3-AHT) as a supportive treatment for cancer-related fatigue. Fifty patients with various cancers (breast, lung, colon, renal, prostate, melanoma, hepatocellular carcinoma) received O2-O3-AHT twice weekly for one month, followed by twice-monthly maintenance therapy. Fatigue severity was

Read More »
June 26, 2025 No Comments

The Use of Intravenous Vitamin C as a Supportive Therapy for a Patient with Glioblastoma Multiforme

This case report documents the extended survival of a female patient with glioblastoma multiforme (GBM), who lived over four years following diagnosis—far surpassing the typical median survival of around 12 months. Standard care included surgical resection, radiation, and temozolomide chemotherapy, alongside adjunctive high-dose intravenous vitamin C (IVC) therapy administered two

Read More »
June 26, 2025 No Comments

Treatment of Pancreatic Cancer with Intravenous Vitamin C: A Case Report

This case report details the treatment of a patient with stage IV poorly differentiated pancreatic ductal adenocarcinoma (PDA) using intravenous pharmacologic ascorbic acid (PAA) as the sole therapy. The patient survived nearly four years post-diagnosis, exhibiting objective tumor regression and stable disease, as evidenced by serial CT/PET imaging. The proposed

Read More »
June 26, 2025 No Comments

The Influence of Isorel on Advanced Colorectal Cancer

This 2003 randomized, controlled clinical study investigated the impact of Isorel, a mistletoe extract (Viscum album L.), as an adjunct therapy in patients with advanced colorectal cancer (Dukes C and D stages). Participants were allocated into three groups: surgery alone, surgery plus standard 5-fluorouracil (5-FU) chemotherapy, and surgery plus chemotherapy

Read More »
June 26, 2025 No Comments

The Long-Term Survival of a Patient With Pancreatic Cancer With Metastases to the Liver After Treatment With the Intravenous Alpha-Lipoic Acid/Low-Dose Naltrexone Protocol

This 2006 case report describes the long-term survival of a patient with metastatic pancreatic cancer following treatment with an integrative protocol centered around intravenous alpha-lipoic acid (ALA) and oral low-dose naltrexone (LDN). Diagnosed with pancreatic cancer and liver metastases and given a poor prognosis, the patient underwent the ALA/LDN regimen

Read More »
June 26, 2025 No Comments

The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol

This 2018 case report presents the clinical course of a patient with Stage IV renal cell carcinoma who achieved long-term survival following an integrative treatment protocol initiated after failure of conventional therapies. The regimen included intravenous α-lipoic acid, vitamin C, low-dose naltrexone (LDN), hydroxycitrate, and comprehensive lifestyle changes. The treatment

Read More »
June 26, 2025 No Comments

The Use of Antioxidants with First-Line Chemotherapy in Two Cases of Ovarian Cancer

This case report presents two patients with advanced epithelial ovarian cancer (Stage IIIC) who underwent standard first-line chemotherapy with carboplatin and paclitaxel, combined with high-dose antioxidant therapy. The antioxidant regimen included oral supplements (vitamin C, vitamin E, beta-carotene, coenzyme Q10, and a multivitamin/mineral complex) and intravenous vitamin C (60 grams

Read More »
June 26, 2025 No Comments

Safety of herbal medicine use during chemotherapy in patients with ovarian cancer: a “bedside-to-bench” approach

This study evaluated the safety and potential interactions of herbal medicines used by ovarian cancer patients undergoing chemotherapy. Among 98 patients, 42.9% reported using or intending to use herbal products. Five herbs—wheatgrass, European mistletoe, ginger, ephedra, and Oriental mistletoe—were selected for in vitro analysis. Results indicated that ginger and both

Read More »
June 26, 2025 No Comments

The Case for Mistletoe in the Treatment of Laryngeal Cancer

This 2014 case report details a 68-year-old patient with aggressive, non-resectable laryngeal carcinoma who achieved complete remission following mistletoe therapy after failing to respond to chemoradiotherapy and salvage laryngectomy. The patient received high-dose intratumoral applications of Viscum album extract (mistletoe), leading to full recovery and hospital discharge. The report underscores

Read More »
June 26, 2025 No Comments

Integrating Dietary Supplements into Cancer Care

This 2013 review article examines the use of dietary supplements (DS) in oncology, highlighting that a majority of cancer patients incorporate DS into their treatment regimens. The authors discuss commonly used supplements such as curcumin, glutamine, vitamin D, Maitake mushrooms, fish oil, green tea, milk thistle, Astragalus, melatonin, and probiotics.

Read More »
June 26, 2025 No Comments